SCHEMBL5240236

SCHEMBL5240236

O=C1CCCN1N=C(Cc1ccnc2ccccc12)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FAAH O00519 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.37
TACR1 P25103 2/20 0.37
RAB9A P51151 2/20 0.35
HSD17B10 Q99714 2/20 0.34
USP2 O75604 1/20 0.34
BCHE P06276 1/20 0.34
CFTR P13569 1/20 0.34
ALOX15 P16050 1/20 0.34
ACHE P22303 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
GOPC Q9HD26 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5240230 1.00 CYP1A2 (0.45) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5235146 0.91 CYP1A2 (0.40) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5235150 0.91 CYP1A2 (0.40) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5233927 0.89 KDR (0.38) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5233924 0.89 KDR (0.38) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5239587 0.89 AR (0.39) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5239591 0.89 AR (0.39) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5239266 0.87 CYP1A2 (0.41) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5239257 0.87 CYP1A2 (0.41) CYP1A2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL5235216 0.86 KDR (0.44) CYP1A2LMNATACR1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397364-B1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS LILLY CO ELI (US) 2007-07-25 EP disclosed